FI951078A0 - Retrovirusinfektion inhibitio - Google Patents

Retrovirusinfektion inhibitio

Info

Publication number
FI951078A0
FI951078A0 FI951078A FI951078A FI951078A0 FI 951078 A0 FI951078 A0 FI 951078A0 FI 951078 A FI951078 A FI 951078A FI 951078 A FI951078 A FI 951078A FI 951078 A0 FI951078 A0 FI 951078A0
Authority
FI
Finland
Prior art keywords
inhibition
retroviral infection
slpi
prevention
methods
Prior art date
Application number
FI951078A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951078A (fi
Inventor
Stephen Eisenberg
Sharon M Wahl
Robert C Thompson
Original Assignee
Amgen Boulder Inc
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc, Us Health filed Critical Amgen Boulder Inc
Publication of FI951078A publication Critical patent/FI951078A/fi
Publication of FI951078A0 publication Critical patent/FI951078A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
FI951078A 1992-09-09 1995-03-08 Retrovirusinfektion inhibitio FI951078A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (en) 1992-09-09 1993-09-09 Inhibitiion of retrovirus infection

Publications (2)

Publication Number Publication Date
FI951078A FI951078A (fi) 1995-03-08
FI951078A0 true FI951078A0 (fi) 1995-03-08

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951078A FI951078A0 (fi) 1992-09-09 1995-03-08 Retrovirusinfektion inhibitio

Country Status (23)

Country Link
EP (1) EP0666755B1 (uk)
JP (2) JP3517238B2 (uk)
KR (1) KR100273620B1 (uk)
AT (1) ATE238062T1 (uk)
AU (1) AU681350B2 (uk)
CA (1) CA2141951C (uk)
CZ (1) CZ286953B6 (uk)
DE (1) DE69332904T2 (uk)
DK (1) DK0666755T3 (uk)
ES (1) ES2197153T3 (uk)
FI (1) FI951078A0 (uk)
HU (1) HU218892B (uk)
NO (1) NO315546B1 (uk)
NZ (1) NZ256246A (uk)
OA (1) OA10133A (uk)
PL (1) PL307864A1 (uk)
PT (1) PT666755E (uk)
RO (1) RO116164B1 (uk)
RU (1) RU2126266C1 (uk)
SG (1) SG48115A1 (uk)
SK (1) SK281127B6 (uk)
UA (1) UA41338C2 (uk)
WO (1) WO1994006454A2 (uk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507165A (pt) * 1994-03-23 1997-09-09 Tokyo Tanase Company Limited Inibidor da triptase clara agente terapêutico ou profilático para doenças virais processo terapêutico para doenças virais e uso da antileucoprotease
WO1997003694A1 (fr) * 1995-07-24 1997-02-06 Tokyo Tanabe Company Limited Remede contre les affections virales
EP0861085B1 (en) 1995-11-13 2005-07-20 Vitaleech Bioscience N.V. Anti-viral isolates obtained from leeches
AU780121B2 (en) * 1999-05-13 2005-03-03 Japan Science And Technology Agency Inhibitors for viral infection targeting integrase N-terminal region
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
WO2005046732A2 (en) 2003-11-04 2005-05-26 THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH Methods and compositions for the inhibition of hiv-1 replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
JP2930713B2 (ja) * 1989-08-16 1999-08-03 カイロン コーポレイション タンパク質ホルモン形成の抑制用の組成物およびその使用法
AU644621B2 (en) * 1989-12-18 1993-12-16 Transgene S.A. Pharmaceutical composition for treating or preventing retroviral infections
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
DK0666755T3 (da) 2003-08-04
JP2004002455A (ja) 2004-01-08
RO116164B1 (ro) 2000-11-30
SG48115A1 (en) 1998-04-17
PL307864A1 (en) 1995-06-26
HU218892B (hu) 2000-12-28
CZ55995A3 (en) 1996-01-17
WO1994006454A3 (en) 1994-08-18
FI951078A (fi) 1995-03-08
DE69332904D1 (de) 2003-05-28
WO1994006454A2 (en) 1994-03-31
EP0666755B1 (en) 2003-04-23
RU2126266C1 (ru) 1999-02-20
KR950703357A (ko) 1995-09-20
NO950897D0 (no) 1995-03-08
NZ256246A (en) 1997-08-22
JP3517238B2 (ja) 2004-04-12
HU9500682D0 (en) 1995-04-28
OA10133A (en) 1996-12-18
CA2141951A1 (en) 1994-03-31
SK29795A3 (en) 1997-02-05
ATE238062T1 (de) 2003-05-15
DE69332904T2 (de) 2003-11-06
NO315546B1 (no) 2003-09-22
UA41338C2 (uk) 2001-09-17
SK281127B6 (sk) 2000-12-11
AU681350B2 (en) 1997-08-28
EP0666755A1 (en) 1995-08-16
KR100273620B1 (ko) 2000-12-15
RU95109909A (ru) 1997-03-27
JPH08505042A (ja) 1996-06-04
CA2141951C (en) 2007-04-24
AU4853093A (en) 1994-04-12
ES2197153T3 (es) 2004-01-01
NO950897L (no) 1995-03-08
PT666755E (pt) 2003-09-30
CZ286953B6 (en) 2000-08-16
HUT75126A (en) 1997-04-28

Similar Documents

Publication Publication Date Title
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
NO932620L (no) Amindiol-proteaseinhibitorer
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NO983688L (no) Serin-protease-inhibitorer
MX9706947A (es) Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
NO962017L (no) 5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler
DE69625183T2 (de) Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen
NO983991L (no) Serin-protease-inhibitorer
MD960172A (en) 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
FI951078A0 (fi) Retrovirusinfektion inhibitio
MX9304351A (es) Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed